Having trouble accessing articles? Reset your cache.

Alexza plummets on AZ-004 complete response

Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) fell $1.65 (54%) to $1.38 on Monday after FDA issued a complete response letter for an NDA

Read the full 216 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE